2009
DOI: 10.1016/j.bmcl.2009.09.003
|View full text |Cite
|
Sign up to set email alerts
|

Pyrimidine-based antagonists of h-MCH-R1 derived from ATC0175: In vitro profiling and in vivo evaluation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2012
2012
2013
2013

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 20 publications
0
2
0
Order By: Relevance
“…Multiple MCHR1 antagonists have also shown dose-dependent and sustained efficacy in chronic models of obesity (Kym et al, 2005; Souers et al, 2005a,b, 2007; Vasudevan et al, 2005a,b; Carpenter et al, 2006; Hertzog et al, 2006; Tavares et al, 2006a,b; Mendez-Andino and Wos, 2007; Mendez-Andino et al, 2007; Gehlert et al, 2009; Ito et al, 2009; Semple et al, 2009; Suzuki et al, 2009; Hadden et al, 2010; Mihalic et al, 2012; Sasmal et al, 2012a,b). At the highest dose tested in DIO mice, ranging from 10 to 100 mpk, weight loss ranged from 5% at 5 days to 33% at 238 days (Ito et al, 2009; Mihalic et al, 2012).…”
Section: Pharmacologic Studies Confirm a Role For Mch In Energy Homeomentioning
confidence: 99%
“…Multiple MCHR1 antagonists have also shown dose-dependent and sustained efficacy in chronic models of obesity (Kym et al, 2005; Souers et al, 2005a,b, 2007; Vasudevan et al, 2005a,b; Carpenter et al, 2006; Hertzog et al, 2006; Tavares et al, 2006a,b; Mendez-Andino and Wos, 2007; Mendez-Andino et al, 2007; Gehlert et al, 2009; Ito et al, 2009; Semple et al, 2009; Suzuki et al, 2009; Hadden et al, 2010; Mihalic et al, 2012; Sasmal et al, 2012a,b). At the highest dose tested in DIO mice, ranging from 10 to 100 mpk, weight loss ranged from 5% at 5 days to 33% at 238 days (Ito et al, 2009; Mihalic et al, 2012).…”
Section: Pharmacologic Studies Confirm a Role For Mch In Energy Homeomentioning
confidence: 99%
“…Any deviation from this pattern should therefore warrant further investigation. Figure 9.38.3 shows the pattern of food intake after administration of a compound, which chronically inhibits gastric emptying (Semple et al, 2009), characterized by an increasing effect over days. Inhibition of gastric emptying can be measured by weighing gastric contents after ingestion of fixed amounts of solid or liquid meals (Guillaume et al, 2008;Maida et al, 2008).…”
Section: Potential Confounding Factors Affecting Food Intake In Pharm...mentioning
confidence: 99%